167 related articles for article (PubMed ID: 33177242)
1. Integrated analysis of transcriptomic and metabolomic data demonstrates the significant role of pyruvate carboxylase in the progression of ovarian cancer.
Shang H; Zheng J; Tong J
Aging (Albany NY); 2020 Nov; 12(21):21874-21889. PubMed ID: 33177242
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential biomarkers and metabolic pathways based on integration of metabolomic and transcriptomic data in the development of breast cancer.
Yang Y; Zhu Y; Li X; Zhang X; Yu B
Arch Gynecol Obstet; 2021 Jun; 303(6):1599-1606. PubMed ID: 33791842
[TBL] [Abstract][Full Text] [Related]
3. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry analysis shows the biosynthetic pathways supported by pyruvate carboxylase in highly invasive breast cancer cells.
Phannasil P; Ansari IH; El Azzouny M; Longacre MJ; Rattanapornsompong K; Burant CF; MacDonald MJ; Jitrapakdee S
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):537-551. PubMed ID: 27890529
[TBL] [Abstract][Full Text] [Related]
5. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Potential Role of NTPCR in Epithelial Ovarian Cancer by Integrating Transcriptomic and Metabolomic Analysis.
Shang H; Zhang H; Ren Z; Zhao H; Zhang Z; Tong J
Front Genet; 2021; 12():695245. PubMed ID: 34539736
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome sequencing identifies genes associated with invasion of ovarian cancer.
Peng X; Yu M; Chen J
J Int Med Res; 2020 Sep; 48(9):300060520950912. PubMed ID: 32878513
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis based gene expression profiling reveals functional genes in ovarian cancer.
Zhao L; Li Y; Zhang Z; Zou J; Li J; Wei R; Guo Q; Zhu X; Chu C; Fu X; Yue J; Li X
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33135729
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
[TBL] [Abstract][Full Text] [Related]
11. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
13. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.
Wang ZQ; Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Guillemette C; Gobeil S; Macdonald E; Vanderhyden B; Bachvarov D
Oncotarget; 2015 Oct; 6(31):31522-43. PubMed ID: 26372729
[TBL] [Abstract][Full Text] [Related]
14. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
16. Large-scale profiling of metabolic dysregulation in ovarian cancer.
Ke C; Hou Y; Zhang H; Fan L; Ge T; Guo B; Zhang F; Yang K; Wang J; Lou G; Li K
Int J Cancer; 2015 Feb; 136(3):516-26. PubMed ID: 24895217
[TBL] [Abstract][Full Text] [Related]
17. Systematic module approach identifies altered genes and pathways in four types of ovarian cancer.
Liu J; Wang HL; Ma FM; Guo HP; Fang NN; Wang SS; Li XH
Mol Med Rep; 2017 Dec; 16(6):7907-7914. PubMed ID: 28983627
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Pyruvate Carboxylase Is Correlated With Colorectal Cancer Progression and Supports Growth of Invasive Colon Cancer HT-29 Cell Line.
Ngamkham J; Thuwajit C; Thuwajit P; Khamwachirapithak P; Lertsuwan K; Charoensawan V; Jitrapakdee S
Anticancer Res; 2020 Nov; 40(11):6285-6293. PubMed ID: 33109566
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate Carboxylase Is Up-Regulated in Breast Cancer and Essential to Support Growth and Invasion of MDA-MB-231 Cells.
Phannasil P; Thuwajit C; Warnnissorn M; Wallace JC; MacDonald MJ; Jitrapakdee S
PLoS One; 2015; 10(6):e0129848. PubMed ID: 26070193
[TBL] [Abstract][Full Text] [Related]
20. Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression.
Gupta R; Yang Q; Dogra SK; Wajapeyee N
Oncogene; 2017 Jul; 36(28):4014-4024. PubMed ID: 28288142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]